Fastroids.eu

Stenabolic (SR9009) REWIX Labs

Retail
Price:

67.00

Quantity
POPULARITY
3/5

Usage: SARMS

Stenabolic (SR9009) 5mg x 100tb

STENABOLIC (SR 9009)

SR-9009 is an agonist of REV-ERB alpha and beta nuclear receptors. It affects both receptors in muscles and peripheral tissues, which provides a positive effect on building strength and endurance. It improves glucose and fat metabolism in muscles and improves oxygen utilization. In addition, it affects receptors located in the brain – it has a positive effect on circadian rhythms and regulates the biological clock, making it very helpful for people with shift work or frequent travelers. It is an agent with high androgenic potential and low androgenic potential. The Anabolic: androgenic ratio is much more favorable than that of testosterone. increased strength and endurance, accelerated muscle mass growth and regeneration – it would not be an exaggeration to say that   SR-9009is an excellent alternative to testosterone with fewer side effects.

ACTION

SR9009 stimulates and activates Rev-ErbA, which increases mitochondria. This, in turn, leads to increased endurance, endurance and exercise capacity. R9009, also known as Stenabolic, is a synthetic drug designed to study circadian rhythm. It has been shown to increase endurance, reduce anxiety and lower cholesterol, weight and reduce inflammation. All effects observed with SR9009 come from the activation of REV-ERB (NR1D1, NR1D2) in the body. In addition to affecting the circadian rhythm (inhibiting BMAL1 production), REV-ERB affects many other functions related to energy production. REV-ERB is found mainly in the liver, muscles and adipose tissue. REV-ERB affects the rhythm of 90% of approximately 900 circadian-controlled genes in the liver. It turns off the genes that produce glucose without changing insulin sensitivity. It also turns on genes that generate new fat cells and reduces the inflammatory response. REV-ERB supports fat burning, increases the activity of mitochondria and promotes the creation of new ones, while reducing the destruction of old mitochondria. REV-ERB turns off genes responsible for fat storage and reduces the production of triglycerides.

ADVANTAGES

• Building lean muscle mass
• Losing fat tissue
• Reduces fatigue
• Improves concentration
• Regeneration and healing of micro-injuries – high anabolic potential • ”
Pump” effect beneficial during strength training
• Improved performance
• Antioxidant effect
• Improved insulin sensitivity and lipid profile
• Favorable safety profile
• Increased bone mineral density
• Slightly increased red blood cell production
• Counteracts neurodegeneration
• Safe for women – low androgenic potential

DOSAGE

The initial dose is 10mg, maximum 20mg per day.
The suggested target daily dose is 10-40 mg divided into 3-4 daily doses due to the short half-life – 3 hours. Your dose of SR9009 must be spread throughout the day. If you don’t spread out your dose, you won’t get optimal results. Here is an example of a dosage – Example of a day – 20mg dosage:

• 07:00. First dose 5mg.
• 11:00 (noon). Second dose of 5 mg.
• 15.00. Third dose of 5 mg.
• 7 p.m. Fourth and final dose of 5 mg.

It is recommended to administer the last dose 3-4 hours before going to bed, not immediately before, to avoid insomnia.

 

POSSIBLE SIDE EFFECTS

• Insomnia
• Slightly increased myostatin levels
• Long cycles may cause partial blockage of the pituitary axis and suppression of testosterone production

TESTS

Most mouse experiments used a dose of 100 mg/kg administered intraperitoneally; that is, injected directly into the body cavity. Mice injected with SR9009 for 7 days lost weight due to a decrease in fat mass. This had no effect on food intake. Similarly, obese mice (diet-induced obesity) that were injected with SR9009 for 30 days lost 60% more body weight than control animals. The levels of triglycerides, total cholesterol, free fatty acids and insulin in the blood also decreased. SR9009 administered for 7 to 10 days reduced blood triglyceride and total cholesterol levels in mice. Mice treated with SR9009 for 30 days showed increased endurance. Genetically modified mice susceptible to arteriosclerosis were treated with SR9009 for 7 weeks.

Related products